APHY up 5.31%
January 24, 2007: Assured Pharmacy, Inc. (OTC Bulletin Board: APHY - News), a specialty pharmacy providing custom services for patients with chronic pain and other long-term care conditions, announced today that it has completed a $2,458,500 financing consisting of 18% Unsecured Convertible Debentures (the "Debentures") and warrants. Headquartered in Irvine, CA, Assured currently operates five retail locations on the west coast, with two in California (Santa Ana and Riverside), two in Oregon (both in Portland) and one in Washington (Kirkland/Seattle). Shares currently at .42 up from .37, Assured Pharmacy is progressing nicely. Shares are expected to reach .50-1.50 during ’07. Profitability is projected to occur in Q3, 2007. Note that the average patient during Q2 is providing annualized revenues to APHY of approximately $6,380 (3.5 scripts/month X $152/script X 12). Note that the 1,719 patients using Assured Pharmacy’s services during Q2, 2006 represented only .02% of the total estimated U.S. severe chronic pain market. Andrew Brown, Managing Director of ROI Group Associates, commented, "Assured Pharmacy is an exceptional growth opportunity in our opinion. The rare combination of a potentially huge, largely untapped, business opportunity, where management has made a significant financial commitment, makes us very excited about representing Assured Pharmacy. With 5 pharmacies already cash flow positive on an operational basis, Assured's business model appears to be well-established, pointing to a clear path for future growth. The sheer size of Assured's target audience, and the huge void of quality options for them to patronize, results in our belief that Assured Pharmacy is one of the best opportunities we have seen in years," concluded Mr. Brown.